Micro Interventional Devices, Inc. specializes in developing advanced medical devices for minimally invasive heart valve procedures. The company operates in the medical technology market, focusing on providing solutions for structural heart disease. Its primary clients include hospitals, cardiac surgeons, and interventional cardiologists who require cutting-edge tools for transapical and transfemoral access and closure. The business model revolves around the development and commercialization of proprietary anchoring technology, which allows for rapid deployment during procedures, thereby reducing the need for open surgical techniques. Revenue is generated through the sale of these specialized devices, which are FDA cleared and CE Mark approved for market use. The company's flagship product, the Permaseal Transapical Access and Closure Device, facilitates catheter-based procedures, offering a safer and more efficient alternative to traditional methods.

Keywords: anchoring technology, heart valve, minimally invasive, transapical, transfemoral, cardiac surgeons, interventional cardiologists, structural heart disease, Permaseal, medical devices.